Research finds more than 15m in US, UK, Germany and France with MASH have not been diagnosed
More than 15 million people in the US, UK, Germany and France do not know they have the most aggressive form of fatty liver disease, according to research.
Metabolic dysfunction-associated steatotic liver disease (MASLD) – the formal name for non-alcoholic fatty liver disease – occurs in people who drink no or minimal amounts of alcohol whose liver contains more than 5% fat.
About two-thirds of patients with type 2 diabetes are thought to have the condition, which is also associated with obesity, heart and circulatory disease.
Approximately 5% of adults globally have the most aggressive form of MASLD. Metabolic dysfunction-associated steatohepatitis (MASH) causes fibrosis (scarring) and can lead to cirrhosis and is linked to greater risk of cardiovascular disease, chronic kidney disease and liver cancer.
I would argue that the most effective way to reverse it is to fast. The best way to maintain and treat while not fasting would be a diet low in carbohydrates.